Overview
The NIH Rapid Acceleration of Diagnostics (RADx®) Initiative aims to accelerate the development and commercialization of diagnostic tests to detect the SARS-CoV-2 virus. Two RADx programs within this Initiative—RADx Tech and RADx ATP (Advanced Technology Platforms) —are supporting late stage development of innovative point-of-care and home-based tests, as well as improved clinical laboratory tests that will increase the capacity of testing in the U.S. RADx-supported authorized tests are listed here.
Key Terms Used in Project Details
Data Updated: 06/30/2022